A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors
NCT ID: NCT00706875
Last Updated: 2018-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
59 participants
OBSERVATIONAL
2008-06-30
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We would like to know more about the health, quality of life and pregnancies of women treated for GTD. This information will be used to try and improve the treatments for women who have this disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia
NCT03703271
Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors
NCT00521118
Quality of Life in Survivors of Gynecologic Cancer
NCT00003795
Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia
NCT04756713
Early Detection of Cancers in Low Resource Countries
NCT01178736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
30 patients survived GTD post treatment for 0 - 5 years.
questionnaire
A patient questionnaire, which includes validated instruments. Data collection methods are as follows:
* In person at the medical appointment
* Over the telephone
* Mailed with self-addressed return envelope and prepaid postage
* E-mailed and returned by e-mail, fax or self-addressed envelope and pre-paid postage
2
30 patients survived GTD post treatment 6 - 10+ years.
questionnaire
A patient questionnaire, which includes validated instruments. Data collection methods are as follows:
* In person at the medical appointment
* Over the telephone
* Mailed with self-addressed return envelope and prepaid postage
* E-mailed and returned by e-mail, fax or self-addressed envelope and pre-paid postage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire
A patient questionnaire, which includes validated instruments. Data collection methods are as follows:
* In person at the medical appointment
* Over the telephone
* Mailed with self-addressed return envelope and prepaid postage
* E-mailed and returned by e-mail, fax or self-addressed envelope and pre-paid postage
questionnaire
A patient questionnaire, which includes validated instruments. Data collection methods are as follows:
* In person at the medical appointment
* Over the telephone
* Mailed with self-addressed return envelope and prepaid postage
* E-mailed and returned by e-mail, fax or self-addressed envelope and pre-paid postage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sufficient proficiency in the English language to respond to quality of life surveys
* Age ≥ 18 years
* Benign or malignant disease
* Treated with surgery and/or chemotherapy or observation
Exclusion Criteria
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth Jewell, MD
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-040
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.